Kite Pharma

Kite Pharma, Inc.
TypeSubsidiary
Nasdaq: KITE
IndustryBiopharmaceutical
Founded2009 (2009)
FounderArie Belldegrun and Joshua Kazam
FateAcquired by Gilead Sciences
Headquarters,
Key people
  • Christi Shaw (CEO)
  • Mert Aktar (Head of Corporate Development)
  • Warner Biddle (Global Head of Commercial)
ProductsCancer immunotherapy
Number of employees
2,000
ParentGilead Sciences
Websitewww.kitepharma.com
Footnotes
Key People, Founder

Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.